Published in Immunology on October 01, 1970
Potentiation of the T-lymphocyte response to mitogens. I. The responding cell. J Exp Med (1972) 6.52
Nonspecific and specific immunological mitogenicity by group A streptococcal pyrogenic exotoxins. Infect Immun (1978) 2.35
Multipotent mesenchymal stromal cells express FoxP3: a marker for the immunosuppressive capacity? J Immunother (2011) 1.44
Effect of neuraminidase on the stimulatory capacity of cells in human mixed lymphocyte cultures. Clin Exp Immunol (1971) 1.32
The potentiating, mitogenic and inhibitory effects on lymphocytes in vitro, of macrophages in the lymph nodes of mice 'overloaded' with mycobacterial products. Clin Exp Immunol (1975) 1.21
HSCT recipients have specific tolerance to MSC but not to the MSC donor. J Immunother (2009) 0.96
Antigen-induced suppression of the in vitro lymphocyte response to different antigens and mitogens. Immunology (1972) 0.96
An unusual response of hamster lymphocytes to PHA. Immunology (1973) 0.91
Schistosoma mansoni: autoantibodies and polyclonal B cell activation in infected mice. Clin Exp Immunol (1981) 0.89
Inhibition of antibody formation during continual stimulation with a strong immunogen. Immunology (1974) 0.85
Persistence of human parvovirus B19 in multipotent mesenchymal stromal cells expressing the erythrocyte P antigen: implications for transplantation. Biol Blood Marrow Transplant (2008) 0.83
Characterization of lymphocyte transformation induced by zinc ions. J Cell Biol (1974) 0.82
Lymphocyte surface components. I. Stimulation of enzyme-treated rabbit lymphocytes by non-specific mitogens. Clin Exp Immunol (1971) 0.80
Characterization of the mitogenic and antigenic stimulatory properties of a purified streptolysin O preparation. Clin Exp Immunol (1982) 0.79
Modulation of mitogenic responsiveness by staphylococcal peptidoglycan. Infect Immun (1980) 0.75
The responsiveness of efferent lymph cells to phytohaemagglutinin during the response of the popliteal node to dinitrophenylated bovine serum albumin. Immunology (1979) 0.75
Delayed hypersensitivity in vitro: its mediation by cell-free substances formed by lymphoid cell-antigen interaction. Proc Natl Acad Sci U S A (1966) 12.29
SEPARATION OF VIABLE LYMPHOCYTES FROM HUMAN BLOOD. Lancet (1964) 8.91
Quantitative studies on the mixed lymphocyte interaction in rats. 3. Kinetics of the response. J Exp Med (1968) 4.52
Relationship of in vitro lymphocyte transformation to delayed hypersensitivity in guinea pigs and man. Fed Proc (1990) 4.31
Modification of the antigenic structure of the cell membrane by thymus-leukemia (TL) antibody. Proc Natl Acad Sci U S A (1967) 3.26
Studies on rabbit lymphocytes in vitro. V. The induction of blast transformation with sheep antisera to rabbit IgG subunits. J Exp Med (1967) 2.65
Non-specific induction of cytotoxicity in normal human lymphocytes in vitro: studies of mechanism and specificity of the reaction. Clin Exp Immunol (1969) 1.53
A quantitative study of the stimulation of DNA synthesis in lymph node cell cultures by anti-lymphocyte serum, anti-gamma globulin serum, specific antigen, and phytohemagglutinin. J Exp Med (1969) 1.47
Response to phytohaemagglutinin of lymphocytes from mice treated with anti-lymphocyte globulin. Immunology (1969) 1.41
Induction and suppression of the cytotoxic activity of human lymphocytes in vitro by heterologous anti-lymphocyte serum. Clin Exp Immunol (1969) 1.06
The effect of anti-lymphocyte serum on the response of human and mouse lymphocytes to PHA. Nature (1968) 1.05
Release of migration inhibitory factors from immune rat lymphocytes confronted with histocompatibility antigens. Nature (1969) 1.02
Effect of lymphocyte stimulants on specific antibody synthesis in vitro. Nature (1968) 0.95
Delayed hypersensitivity: specific cell-mediated immunity. Br Med Bull (1967) 0.89
Regulatory effect of antibody on the immune response. Adv Immunol (1968) 6.03
Mitogens as probes for immunocyte activation and cellular cooperation. Transplant Rev (1972) 5.66
Selective induction of DNA synthesis in T and B lymphocytes. Cell Immunol (1972) 4.94
Induction of immunoglobulin and antibody synthesis in vitro by lipopolysaccharides. Eur J Immunol (1972) 4.64
Differential effects of human granulocytes and lymphocytes on human fibroblasts in vitro. Clin Exp Immunol (1968) 3.38
Thymus-independent B-cell induction and paralysis. Adv Immunol (1975) 3.27
Editorial: Immune activation of B cells: evidence for 'one nonspecific triggering signal' not delivered by the Ig receptors. Scand J Immunol (1974) 2.93
Lipopolysaccharide can substitute for helper cells in the antibody response in vitro. Eur J Immunol (1972) 2.58
Subcutaneous immunoglobulin replacement in patients with primary antibody deficiencies: safety and costs. Lancet (1995) 2.43
Activation of B lymphocytes by locally concentrated concanavalin A. Eur J Immunol (1972) 2.41
Frequency of antigen-sensitive cells to thymus-independent antigens. Cell Immunol (1971) 2.39
Regulation of antibody synthesis against Escherichia coli endotoxin. I. Suppressive effect of endogenously produced and passively transferred antibodies. J Immunol (1968) 2.18
19S antibody production against soluble lipopolysaccharide antigens by individual lymphoid cells in vitro. Nature (1965) 2.12
Mechanism of thymus-independent immunocyte triggering. Mitogenic activation of B cells results in specific immune responses. J Exp Med (1974) 2.04
Induction of DNA synthesis in normal human lymphocyte cultures by antigen-antibody complexes. Clin Exp Immunol (1969) 2.03
Specificiy of lymphocyte-mediated cytotoxicity induced by in vitro antibody-coated target cells. Cell Immunol (1972) 1.93
Studies at the cellular level of the 19S immune response. Acta Pathol Microbiol Scand (1966) 1.93
Molecular basis of B-cell activation. I. Mitogenicity of native and substituted dextrans. Scand J Immunol (1974) 1.87
Persistence of immunogenicity of two complex antigens retained in vivo. Immunology (1968) 1.87
Polyclonal antibody secretion in human lymphocytes induced by killed staphylococcal bacteria and by lipopolysaccharide. Scand J Immunol (1977) 1.82
B lymphocytes can be stimulated by concanavalin A in the presence of humoral factors released by T cells. Eur J Immunol (1972) 1.81
B cell mitogenic properties of thymus-independent antigens. Nat New Biol (1973) 1.80
Multicentre study of a new enzymatic method of cholesterol determination. J Clin Chem Clin Biochem (1984) 1.77
Cytotoxicity of human lymphocytes: antagonism between inducing processes. Nature (1968) 1.76
Reconstitution of the antibody response in vitro of T cell-deprived spleen cells by supernatants from spleen cell cultures. J Immunol (1972) 1.73
Effect of antigenic competition on antigen-sensitive cells and on adoptively transferred immunocompetent cells. Cell Immunol (1970) 1.71
T cell growth factor abrogates concanavalin A-induced suppressor cell function. J Exp Med (1981) 1.68
In vitro activation of mouse lymphocytes in serum-free medium: effect of T and B cell mitogens on proliferation and antibody synthesis. Eur J Immunol (1973) 1.62
Cyclosporin A blocks receptors for HLA-DR antigens on T cells. Nature (1981) 1.61
Differentiation of B cells: sequential appearance of responsiveness to polyclonal activators. Scand J Immunol (1974) 1.57
Technical principles for protoporphyrin-IX-fluorescence guided microsurgical resection of malignant glioma tissue. Acta Neurochir (Wien) (1998) 1.56
The effector cell in antibody-induced cell mediated immunity. Transplant Rev (1973) 1.56
Plaque-formation by non-immune and x-irradiated lymphoid cells on monolayers of mouse embryo cells. Nature (1965) 1.55
Non-specific induction of cytotoxicity in normal human lymphocytes in vitro: studies of mechanism and specificity of the reaction. Clin Exp Immunol (1969) 1.53
Requirement for adherent cells in the primary and secondary immune response in vitro. Eur J Immunol (1972) 1.51
Immunological unresponsiveness to thymus-independent antigens: two fundamentally different genetic mechanisms of B-cell unresponsiveness to dextran. J Exp Med (1977) 1.50
Lipopolysaccharides can convert heterologous red cells into thymus-independent antigens. Cell Immunol (1972) 1.48
Spleen cells from animals tolerant to a thymus-dependent antigen can be activated by lipopolysaccharide to synthesize antibodies against the tolerogen. J Exp Med (1976) 1.48
Effect of B-cell mitogens on lymphocyte subpopulations possesing C'3 and Fc receptors. J Exp Med (1974) 1.46
Suppressive effect of graft versus host reactions on the immune response to heterologous red cells. Immunology (1971) 1.45
Simultaneous production of interleukin 2, interleukin 4 and interferon-gamma by activated human blood lymphocytes. Eur J Immunol (1990) 1.44
Prolonged survival of H-2 incompatible skin allografts on F1 animals treated with parental lymphoid cells. Immunology (1969) 1.44
Regulation of cellular antibody synthesis. Cellular 7S production and longevity of 7S antigen-sensitive cells in the absence of antibody feedback. J Exp Med (1968) 1.42
Generation of cytotoxic lymphocytes in mixed lymphocyte reactions. I. Specificity of the effector cells. J Exp Med (1973) 1.39
Lymphocytic responses to streptococcal antigens in glomerulonephritic patients. Science (1970) 1.39
The role of 17 beta-hydroxysteroid dehydrogenases. Mol Cell Endocrinol (2004) 1.37
One non-specific signal triggers b lymphocytes. Transplant Rev (1975) 1.36
Characterization of self-reactive B cells by polyclonal B-cell activators. J Exp Med (1977) 1.34
In vitro assay of cell-mediated immunity: the inhibition of migration of sensitized human lymphocytes by HL-A antigens. Clin Exp Immunol (1970) 1.32
In vitro induction of specific immune responses in the absence of serum: requirement for nonspecific T or B cell mitogens. Eur J Immunol (1973) 1.32
Studies on antigen-binding cells. II. Relationship to antigen-sensitive cells. Cell Immunol (1970) 1.31
Role of C'3 and Fc receptors in B-lymphocyte activation. J Exp Med (1975) 1.30
Induction of autoantibodies to red blood cells by polyclonal B-cell activators. Nature (1976) 1.26
Lymphocyte-mediated cytotoxicity against tumor cells. I. Con A activated cytotoxic effector cells exhibit immunological specificity. Cell Immunol (1975) 1.26
Mitogenic properties of the thymus-independent antigen pneumococcal polysaccharide S3. Eur J Immunol (1973) 1.26
Mitogen-induced lymphocyte-mediated cytotoxicity in vitro: effect of mitogens selectively activating T or B cells. Eur J Immunol (1972) 1.26
Immunocyte triggering. Cell Immunol (1970) 1.24
The role of adherent cells in B and T lymphocyte activation. Immunol Rev (1978) 1.23
Differential effect of heterologous anti-lymphocyte serum on antibody-producing cells and antigen-sensitive cells. J Immunol (1968) 1.22
The role of adherent cells in the immune response. Fibroblasts and products released by fibroblasts and peritoneal cells can substitute for adherent cells. Scand J Immunol (1976) 1.21
The polyclonal B-cell-activating property of protein A is not due to its interaction with the FC part of immunoglobulin receptors. Scand J Immunol (1977) 1.19
HLA-DR antigens render resting T cells sensitive to interleukin-2 and induce production of the growth factor in the autologous mixed lymphocyte reaction. Cell Immunol (1981) 1.19
Regulation of cellular antibody synthesis effect of adoptively transferred antibody-producing spleen cells on cellular antibody synthesis. J Immunol (1968) 1.19
Interleukin 4 instructs uncommitted B lymphocytes to switch to IgG1 and IgE. Eur J Immunol (1988) 1.17
Characterization of individual tumor necrosis factor alpha-and beta-producing cells after polyclonal T cell activation. J Immunol Methods (1989) 1.14
Polyclonal B-cell activators induce immunological response to autologous serum proteins. Cell Immunol (1977) 1.13
Immunological unresponsiveness to native dextran B512 in young animals of dextran high responder strains is due to lack of Ig receptors expression. Evidence for a nonrandom expression of V-genes. J Exp Med (1978) 1.10
Reconstitution of immunocompetence in B cells by addition of concanavalin A or concanavalin A-treated thymus cells. Clin Exp Immunol (1973) 1.08
In vitro detection of transplantation immunity: the inhibition of migration of immune spleen cells and peripheral blood leukocytes by specific antigen. J Immunol (1970) 1.08
The alpha chain, not the beta chain of HLA-DR antigens participates in activation of T cells in autologous mixed lymphocyte reaction. Immunogenetics (1982) 1.07
Induction of immunological tolerance requires that the B cells can respond to the polyclonal B-cell-activating properties of the thymus-independent antigens. J Exp Med (1977) 1.06
Mechanism of mercury-induced autoimmunity: both T helper 1- and T helper 2-type responses are involved. Immunology (1999) 1.04
Reversibility of high dose unresponsiveness to concanavalin A in thymus lymphocytes. Immunology (1972) 1.04
Inhibition of in vitro immune responses by a fraction from seminal plasma. Scand J Immunol (1976) 1.03
Irreversible immunological tolerance to thymus-independent antigens is restricted to the clone of B cells having both Ig and PBA receptors for the tolerogen. Scand J Immunol (1978) 1.03
In vitro correlates of transplantation immunity: the release of substances by immune lymphocytes confronted with specific antigens. Surgery (1969) 1.03
Release of migration inhibitory factors from immune rat lymphocytes confronted with histocompatibility antigens. Nature (1969) 1.02
Reactivity of human lymphocytes to aggregated and nonaggregated PPD-tuberculin. Cell Immunol (1972) 1.01
Immune response to haptenated syngeneic and allogeneic lymphocytes. I. Restrictions for B cell activation by haptenated lymphocytes and specificity of the antibodies generated. Scand J Immunol (1978) 1.00
Age-dependent responsiveness to interleukin-6 in B lymphocytes from a systemic lupus erythematosus-prone (NZB x NZW)F1 hybrid. Clin Immunol Immunopathol (1992) 1.00
Fractionation of immunocompetent spleen cells by albumin density gradient centrifugation. Immunology (1970) 0.99
Heterologous antilymphocyte serum: differential effect on antigen-sensitive and antibody-producing cells. Surgery (1968) 0.98
Quantitation of the number of mitogen molecules activating DNA synthesis in T and B lymphocytes. Clin Exp Immunol (1973) 0.98
Discovery of phosphatidylcholines and sphingomyelins as biomarkers for ovarian endometriosis. Hum Reprod (2012) 0.97
Phytoestrogens inhibit human 17beta-hydroxysteroid dehydrogenase type 5. Mol Cell Endocrinol (2001) 0.97
Effect of PPD on the specific immune response to heterologous red cells in vitro. J Immunol (1974) 0.97
Antigen-induced suppression of the in vitro lymphocyte response to different antigens and mitogens. Immunology (1972) 0.96
The concept of immunological surveillance against neoplasia. Transplant Rev (1976) 0.96
Mechanism of b-lymphocyte activation: failure to obtain evidence of a direct role of the Ig receptors in the triggering process. Scand J Immunol (1975) 0.95
Evidence for the existence of self-reactive human B lymphocytes. Clin Exp Immunol (1977) 0.94
Biologic properties of 19 S and 7 S mouse isoantibodies directed against isoantigens of the H-2 system. J Immunol (1966) 0.94
Binding characteristics of aggregated IgGa to rat basophilic leukaemia (RBL) cells and rat mast cells. Immunology (1980) 0.94
Mercury induces polyclonal B cell activation, autoantibody production and renal immune complex deposits in young (NZB x NZW)F1 hybrids. Eur J Immunol (1996) 0.94
Helper interleukins are produced by both CD4 and CD8 splenic T cells after mitogen stimulation. Eur J Immunol (1991) 0.93
Regulation of IgG1 and IgE synthesis by interleukin 4 in mouse B cells. Scand J Immunol (1989) 0.93
Contribution of H-2 and non-H-2 genes in the control of mercury-induced autoimmunity. Int Immunol (2000) 0.93
Immunological tolerance to the thymus-independent antigen dextran can be abrogated by thymus-dependent dextran conjugates: evidence against clonal deletion as the mechanism of tolerance induction. Scand J Immunol (1978) 0.93
Immune response in deep cervical lymph nodes and spleen in the mouse after antigen deposition in different intracerebral sites. Scand J Immunol (1988) 0.91
T and B cell collaboration: induction of motility in small, resting B cells by interleukin 4. Eur J Immunol (1991) 0.91
Concomitant production of different lymphokines in activated T cells. Eur J Immunol (1988) 0.90